Oncovin

   
Google
 
Web NewDrugInformation.com

Oncovin


Drug - Oncovin
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Vincristine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 5MG/VIAL
The potency of the active ingredient(s), Vincristine Sulfate. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Oncovin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 014103
The FDA assigned number to Oncovin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Oncovin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Oncovin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Oncovin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Oncovin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Oncovin.

Oncovin